News
Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...
3d
First Alert 4 on MSNProviders, patients speak out after First Alert 4 Investigation uncovers IV safety concerns at some BJC facilitiesCare providers and patients are now speaking out after a First Alert Four investigation Monday revealed safety concerns with ...
Johnson & Johnson MedTech‘s Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results